Interleukin-7, an experimental growth factor that boosts the immune system, could work best in patients if given after the peak of an infection, a new UW-Madison study says.
IL-7, which the body produces in small amounts, is being studied as a potential therapy. Similar growth factors, such as IL-2, have been used in patients with cancer and AIDS, though with some side effects.